|
|
|
LifeScienceHistory.com - Check us out on Instagram
Take Your Next Career Step with Lundback
British Columbia Life Science Industry Directory
Banner Advertising
Please note that we have a new site: LifeScienceHistory.com, "Where history is made daily" under development and
delayed by COVID-19, to be launched in 2023 replacing British ColumbiaLifeScience.com. Regrettably, we are working with reduced
staffing and the current industry directory is no longer being maintained, but will be replaced with a new and improved
directory upon the launch of the new site. We apologize for the inconvenience.
Neovasc, Inc.
| | | Phone: | (604) 270-4344 | Fax: | (604) 270-4384 | Year Established: | 2002 | Employees: | 48 | Ticker: | NVC | Exchange: | TSX | Main Contact: | Chris Clark, CFO | | Other Contacts: | John Panton, VP, Quality Aaron J. Chalekian, VP, Product Development & Manufacturing Engineering Vicki Bebeau, VP, Clinical & Regulatory Affairs Randy Lane, VP, R&D Fred Colen, President & CEO Shmuel Banai, MD, Medical Director
| | Company Description | Neovasc (formerly Medical Ventures Corp.) is a specialty medical device company that develops, manufactures and markets products for the rapidly growing cardiovascular marketplace. Its products include the Neovasc Reducer™ for the treatment of
refractory angina, the Tiara™ technology in development for the transcatheter treatment of mitral valve disease and a line of advanced biological tissue products that are used as key components in a variety of third-party medical products, such as vascular surgical patches and transcatheter heart valves. | |
|
|
|
|
|